Evidence map›Paper›PMID 34849209›Full record

ArticleComputational and structural biotechnology journal2021

Determinants of efficient modulation of ribosomal traffic jams.

Sophie Vinokour, Tamir Tuller

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sophie VinokourDepartment of Biomedical Engineering, Engineering Faculty, Tel Aviv University, Israel.
Tamir TullerDepartment of Biomedical Engineering, Engineering Faculty, Tel Aviv University, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

mRNA translation is the process which consumes most of the cellular energy. Thus, this process is under strong evolutionary selection for its optimization and rational optimization or reduction of the translation efficiency can impact the cell growth rate. Algorithms for modulating cell growth rate can have various applications in biotechnology, medicine, and agriculture. In this study, we demonstrate that the analysis of these algorithms can also be used for understanding translation. We specifically describe and analyze various generic algorithms, based on comprehensive computational models and whole cell simulations of translation, for introducing silent mutations that can either reduce or increase ribosomal traffic jams along the mRNA. As a result, more or less resources are available, for the cell, promoting improved or reduced cells growth-rate, respectively. We then explore the cost of these algorithms' performance, in terms of their computational time, the number of mutations they introduce, the modified genomic region, the effect on local translation rates, and the properties of the modified genes. Among others, we show that mRNA levels of a gene are much stronger predictors for the effect of its engineering on the ribosomal pool than the ribosomal density of the gene. We also demonstrate that the mutations at the ends of the coding regions have a stronger effect on the ribosomal pool. Furthermore, we report two optimization algorithms that exhibit a tread-off between the number of mutations they introduce and their executing time. The reported results here are fundamental both for understanding the biophysics and evolution of translation, as well as for developing efficient approaches for its engineering.

Indexed as

Codon usageGenome evolutionmRNA translationRibosomal traffic jamsSynthetic biology

Identifiers

PMID34849209
PMCPMC8605386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.